CAMBRIDGE, Massachusetts and TORONTO, Ontario, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a biotechnology company focused on the generation and development of therapeutics ...

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...

CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody ...

Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience Institute and Foundation proudly announce the 2026 World Neuroscience Day ...

JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...

Jupiter Neurosciences is a B2i Digital Featured Company. See the company’s profile at At BIO, Jupiter will discuss its ...

New York, NY, Feb. 22, 2026 (GLOBE NEWSWIRE) -- NeuroYogaNYC, a leader in integrating yoga with scientific research, is thrilled to announce its sixth annual Neuroscience and Yoga Conference, ...

The annual Society for Neuroscience (SfN) conference is currently underway in Chicago. Thousands of neuroscientists have gathered here to discuss the latest topics in neuroscience research. They’re ...

The MarketWatch News Department was not involved in the creation of this content. Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience ...